유리화 세계 시장 규모는 2024년에 95억 3,000만 달러로 평가되었고, 2030년에는 221억 2,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 15.04%의 연평균 성장률(CAGR)을 보일 것으로 예측됩니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 95억 3,000만 달러 |
| 시장 규모 : 2030년 | 221억 2,200만 달러 |
| CAGR : 2025-2030년 | 15.04% |
| 급성장 부문 | 바이오뱅크 |
| 최대 시장 | 북미 |
유리고화는 첨단 냉동 보존 기술로서 의료, 생명공학, 환경보호에 이르기까지 다양한 산업 분야에서 큰 지지를 받고 있습니다. 이 과정에서는 액체를 결정화하지 않고 유리와 같은 고체로 변화시킵니다. 냉동보존에서 유리화는 세포, 조직, 배아 등의 생물학적 샘플을 초저온(보통 -196℃ 또는 -321°F)에서 보존하는 데 특히 효과적입니다. 기존의 냉동 방식과 달리 유리화는 얼음 결정이 형성되지 않기 때문에 세포 손상을 최소화하고 해동 후 생존율을 높입니다.
보조생식술(ART) 분야는 시장 성장의 주요 촉진제입니다. 유리화 기술은 난자 및 배아 보존에 혁명을 일으켜 체외수정(IVF)의 성공률을 크게 향상시켰습니다. 또한, 이 기술은 줄기세포 은행과 재생의학에서도 중요한 역할을 하고 있으며, 첨단 치료와 신약개발에 사용되는 다능성 줄기세포의 장기보존을 용이하게 하고 있습니다. 또한, 임상 연구에 필수적인 생물학적 표본의 안전한 장기 보관을 가능하게 하여 바이오뱅크에서의 채용도 증가하고 있습니다.
새로운 응용 분야로는 장기 보존을 들 수 있는데, 유리화는 기증자 장기의 생존 기간을 연장하고 이식 결과를 향상시킬 수 있는 잠재력을 가지고 있습니다. 또한, 환경 보존 분야에서는 멸종 위기 종의 유전 물질을 보존하고 종자 동결보존을 통해 식물의 생물 다양성을 보호하기 위해 이 기술이 활용되고 있습니다.
바이오뱅킹과 조직공학의 성장
유리고화 기술의 고비용
기술 발전
The Global Vitrification Market was valued at USD 9.53 billion in 2024 and is projected to reach USD 22.12 billion by 2030, registering a compound annual growth rate (CAGR) of 15.04% during the forecast period.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 9.53 Billion |
| Market Size 2030 | USD 22.12 Billion |
| CAGR 2025-2030 | 15.04% |
| Fastest Growing Segment | Biobanks |
| Largest Market | North America |
Vitrification, an advanced cryopreservation technique, has gained significant traction across multiple industries, ranging from medicine and biotechnology to environmental conservation. This process involves the transformation of a liquid into a solid glass-like state without crystallization. In cryopreservation, vitrification is particularly effective for preserving biological samples-such as cells, tissues, and embryos-at ultra-low temperatures (typically -196°C or -321°F). Unlike conventional freezing methods, vitrification eliminates the formation of ice crystals, thereby minimizing cellular damage and enhancing post-thaw viability.
The Assisted Reproductive Technology (ART) sector is a primary driver of market growth. Vitrification has revolutionized oocyte and embryo preservation, substantially improving success rates in in vitro fertilization (IVF) procedures. The technique also plays a vital role in stem cell banking and regenerative medicine, facilitating the long-term storage of pluripotent stem cells for use in advanced therapies and drug discovery. Additionally, vitrification is increasingly adopted in biobanking, where it enables the secure, long-term storage of biological specimens critical for clinical research.
Emerging applications include organ preservation, where vitrification holds the potential to extend the viability of donor organs and enhance transplant outcomes. Moreover, in environmental conservation, the technology is being utilized to preserve genetic material from endangered species and to safeguard plant biodiversity through seed cryopreservation.
Key Market Drivers
Growth in Biobanking and Tissue Engineering
The rapid expansion of biobanking and tissue engineering has become a major catalyst for the global vitrification market. Vitrification's ability to preserve biological specimens in a glass-like state at ultra-low temperatures is essential for ensuring the long-term integrity of samples used in both research and clinical settings.
Biobanks, which store a wide range of biological materials-such as DNA, tissues, and cells-play a crucial role in medical research and therapeutic development. According to the World Health Organization (WHO), over 120 biobanks globally held more than 20 million biological samples as of 2023. The increasing demand for reliable preservation methods has positioned vitrification as a preferred technique due to its superior ability to maintain cellular structure and viability over extended periods.
Key Market Challenges
High Cost of Vitrification Technology
Despite its advantages, the high cost associated with vitrification technology presents a significant barrier to market expansion. The process requires advanced equipment, specialized cryoprotectants, and highly skilled personnel, all of which contribute to elevated capital and operational expenditures.
Establishing a vitrification facility necessitates investment in programmable freezers, cryogenic storage systems, and other high-grade materials. Additionally, continuous maintenance-including liquid nitrogen supply, regulatory compliance, and equipment calibration-further inflates operational costs.
Labor costs are also considerable, as embryologists and laboratory technicians must undergo extensive training to handle sensitive biological materials with precision. Any deviation from protocol can compromise the viability of preserved samples, emphasizing the need for highly qualified professionals.
In developing countries or regions with constrained healthcare budgets, the cost of implementing vitrification technologies can be prohibitive. This limits geographic expansion and restricts access to fertility preservation services for lower-income populations-particularly patients undergoing cancer treatment or gender-affirming care.
Moreover, insurance coverage for fertility preservation is often limited or unavailable, placing the financial burden on patients. The high out-of-pocket expenses discourage many from pursuing vitrification, especially when multiple treatment cycles are required. These economic limitations hinder the widespread adoption of vitrification technologies and raise broader concerns about equitable access to advanced reproductive healthcare.
Key Market Trends
Advancements in Technology
Technological innovation continues to reshape the vitrification landscape, particularly in cryopreservation. Traditional freezing methods often resulted in ice crystal formation, leading to cellular damage. New vitrification techniques eliminate this risk, enabling safer and more effective preservation of cells, tissues, and even entire organs. This progress has significant implications for organ transplantation, IVF, and stem cell therapies.
In materials science, the development of enhanced glass-forming substances with improved resistance to thermal shock and greater transparency is facilitating broader application of vitrification in optics, where precision components such as lenses and prisms require high-quality materials.
The pharmaceutical and biotechnology sectors are also embracing vitrification to develop stable and long-lasting formulations for biopharmaceuticals and vaccines. These methods ensure the preservation of drug efficacy during storage and transport-particularly valuable in resource-limited settings.
In the electronics industry, vitrification is being applied to the production of high-performance devices. Technologies like amorphous silicon and other vitrified materials are central to the manufacture of thin-film transistors and liquid crystal displays (LCDs), contributing to more efficient, lightweight, and visually superior electronic products.
These diverse advancements are expanding the scope of vitrification well beyond traditional biological preservation, positioning it as a transformative technology across multiple high-growth industries.
In this report, the Global Vitrification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Vitrification Market.
Global Vitrification market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: